FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167991765> ?p ?o ?g. }

• W2167991765 endingPage "816" @default.
• W2167991765 startingPage "811" @default.
• W2167991765 abstract "Summary. High‐purity plasma‐derived and recombinant factors are currently safe and efficient treatment for haemophilia. The mid‐term future of haemophilia treatment will involve the use of modified recombinant factors to achieve advantages such as decreased immunogenicity in inhibitor formation and enhanced efficacy as a result of their longer half‐life. In the long‐term, gene therapy and cell therapy strategies will have to be considered. Achievements in cell therapy to date have been using embryonic stem cells and hepatic sinusoidal endothelial cells. Current gene therapy strategies for haemophilia are based on gene transfer using adeno‐associated viruses and non‐viral vectors. Gene therapy for haemophilia is justified because it is a chronic disease and because a very regular factor infusion is required that may involve fatal risks and because it is very expensive. Haemophilia is a very good candidate for use of gene therapy protocols because it is a monogenic disease, and even low expression is able to achieve reversion from a severe to a moderate phenotype. The current trends in haemophilia using adeno‐associated viral vectors are safe but also involve immunogenicity problems. The other alternatives are non‐viral vectors. There have been in recent years relevant advances in non‐viral transfection that raise hope for considering this possibility. Several research groups are opting for this experimental alternative. An expression over 5%, representing a moderate phenotype, for a few months with a high safety, regarding vector, transfected cells, and implantation procedure, would already be a great success. This may represent an intermediate protocol in which the expression levels and times obtained are lower and shorter respectively as compared to viral vectors, but which provide a potential greater patient safety. This may more readily win acceptance among both patients and haematologists because fatal events in the past due to HIV/HCV infection may constrain the implementation of viruses as vectors." @default.
• W2167991765 created "2016-06-24" @default.
• W2167991765 creator A5011081583 @default.
• W2167991765 creator A5053935799 @default.
• W2167991765 date "2009-04-21" @default.
• W2167991765 modified "2023-10-15" @default.
• W2167991765 title "Gene therapy for haemophilia…yes, but…with non-viral vectors?" @default.
• W2167991765 cites W1565635735 @default.
• W2167991765 cites W1819718829 @default.
• W2167991765 cites W1967882987 @default.
• W2167991765 cites W1971342115 @default.
• W2167991765 cites W1973658117 @default.
• W2167991765 cites W1975445946 @default.
• W2167991765 cites W1975453558 @default.
• W2167991765 cites W1976329054 @default.
• W2167991765 cites W1985469721 @default.
• W2167991765 cites W1986965660 @default.
• W2167991765 cites W2011753037 @default.
• W2167991765 cites W2024510704 @default.
• W2167991765 cites W2026473121 @default.
• W2167991765 cites W2026502021 @default.
• W2167991765 cites W2031512640 @default.
• W2167991765 cites W2041157989 @default.
• W2167991765 cites W2041824214 @default.
• W2167991765 cites W2043485621 @default.
• W2167991765 cites W2047707618 @default.
• W2167991765 cites W2052207235 @default.
• W2167991765 cites W2066304010 @default.
• W2167991765 cites W2072373173 @default.
• W2167991765 cites W2076155640 @default.
• W2167991765 cites W2077097982 @default.
• W2167991765 cites W2078217312 @default.
• W2167991765 cites W2083221557 @default.
• W2167991765 cites W2084015767 @default.
• W2167991765 cites W2089865394 @default.
• W2167991765 cites W2090957277 @default.
• W2167991765 cites W2091134968 @default.
• W2167991765 cites W2102563626 @default.
• W2167991765 cites W2106544289 @default.
• W2167991765 cites W2109215179 @default.
• W2167991765 cites W2111742323 @default.
• W2167991765 cites W2126052040 @default.
• W2167991765 cites W2129463341 @default.
• W2167991765 cites W2153867928 @default.
• W2167991765 cites W2166040205 @default.
• W2167991765 cites W2168689756 @default.
• W2167991765 cites W2171936155 @default.
• W2167991765 cites W4231156276 @default.
• W2167991765 doi "https://doi.org/10.1111/j.1365-2516.2009.02010.x" @default.
• W2167991765 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19432929" @default.
• W2167991765 hasPublicationYear "2009" @default.
• W2167991765 type Work @default.
• W2167991765 sameAs 2167991765 @default.
• W2167991765 citedByCount "11" @default.
• W2167991765 countsByYear W21679917652012 @default.
• W2167991765 countsByYear W21679917652013 @default.
• W2167991765 countsByYear W21679917652014 @default.
• W2167991765 countsByYear W21679917652016 @default.
• W2167991765 countsByYear W21679917652019 @default.
• W2167991765 crossrefType "journal-article" @default.
• W2167991765 hasAuthorship W2167991765A5011081583 @default.
• W2167991765 hasAuthorship W2167991765A5053935799 @default.
• W2167991765 hasConcept C104317684 @default.
• W2167991765 hasConcept C10882517 @default.
• W2167991765 hasConcept C111599444 @default.
• W2167991765 hasConcept C126322002 @default.
• W2167991765 hasConcept C1491633281 @default.
• W2167991765 hasConcept C159047783 @default.
• W2167991765 hasConcept C187212893 @default.
• W2167991765 hasConcept C203014093 @default.
• W2167991765 hasConcept C2777081929 @default.
• W2167991765 hasConcept C2777232031 @default.
• W2167991765 hasConcept C2778385053 @default.
• W2167991765 hasConcept C2779134260 @default.
• W2167991765 hasConcept C2780868878 @default.
• W2167991765 hasConcept C32470452 @default.
• W2167991765 hasConcept C40767141 @default.
• W2167991765 hasConcept C43953973 @default.
• W2167991765 hasConcept C54009773 @default.
• W2167991765 hasConcept C54355233 @default.
• W2167991765 hasConcept C60644358 @default.
• W2167991765 hasConcept C71924100 @default.
• W2167991765 hasConcept C86803240 @default.
• W2167991765 hasConcept C8891405 @default.
• W2167991765 hasConcept C92087593 @default.
• W2167991765 hasConceptScore W2167991765C104317684 @default.
• W2167991765 hasConceptScore W2167991765C10882517 @default.
• W2167991765 hasConceptScore W2167991765C111599444 @default.
• W2167991765 hasConceptScore W2167991765C126322002 @default.
• W2167991765 hasConceptScore W2167991765C1491633281 @default.
• W2167991765 hasConceptScore W2167991765C159047783 @default.
• W2167991765 hasConceptScore W2167991765C187212893 @default.
• W2167991765 hasConceptScore W2167991765C203014093 @default.
• W2167991765 hasConceptScore W2167991765C2777081929 @default.
• W2167991765 hasConceptScore W2167991765C2777232031 @default.
• W2167991765 hasConceptScore W2167991765C2778385053 @default.
• W2167991765 hasConceptScore W2167991765C2779134260 @default.
• W2167991765 hasConceptScore W2167991765C2780868878 @default.

• next